UNC study could lead to a treatment for Angelman syndrome
An interdisciplinary team of UNC scientists say they have found a way to “awaken” the paternal allele of Ube3a, which could lead to a potential treatment strategy for AS. Their results were published online by the journal Nature.
UNC Health Care, BCBSNC open Carolina Advanced Health practice
Carolina Advanced Health, a new primary care physician practice from UNC Health Care and Blue Cross and Blue Shield of North Carolina (BCBSNC) specializing in the treatment of adults with chronic medical conditions, opened Wednesday, Dec. 7.
Clinical trial for muscular dystrophy demonstrates safety of custom...
Researchers at the University of North Carolina at Chapel Hill have shown that it is safe to cut and paste together different viruses in an effort to create the ultimate vehicle for gene therapy.
Study: Mycophenolate is superior to azathioprine as treatment for l...
An international study finds that the immunosuppressant drug mycophenolate mofetil is superior to azathioprine, an older immunosuppressant, as a maintenance therapy for lupus nephritis. Dr. Mary Anne Dooley of UNC is first author of the study.
Scarring a necessary evil to prevent further damage after heart attack
Researchers have long sought ways to avoid scarring of the heart after a heart attack. But now new research from the University of North Carolina at Chapel Hill School of Medicine shows that interrupting this process can weaken heart function even further.
Growing without cell division
An international team of scientists, including biologists from the University of North Carolina at Chapel Hill, may have pinpointed for the first time the mechanism responsible for cell polyploidy, a state in which cells contain more than 2 paired sets of chromosomes.